Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
An accomplished R&D leader and champion of the application of AI to drug discovery
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Subscribe To Our Newsletter & Stay Updated
